111328 ⎘
ssRNA viruses positive-sense; Details; Flaviviridae; Flavivirus, e.g. yellow fever virus, dengue, JEV; Methods of inactivation or attenuation by genetic engineering
USE OF DENGUE VACCINE IN PREGNANT AND/OR BREASTFEEDING SUBJECTS
#2COMBINATION THERAPY OF ONCOLYTIC VIRUS DRUGS FOR CANCER TREATMENT
#3SELF-AMPLIFYING mRNA VACCINE BASED ON Z7 GENOME
#4DEVELOPMENT OF DENGUE VIRUS VACCINE COMPONENTS
#5Compositions and Methods for Dengue Virus Chimeric Constructions in Vaccines
#6E PROTEIN-MUTATED WEST NILE VIRUS USED AS LIVEATTENUATED VACCINE AND ONCOLYTIC DRUG FOR CANCER THERAPY
#7DEOPTIMIZED YELLOW FEVER VIRUS AND METHODS AND USES THEREOF
#8LARGE-SCALE FLAVIVIRAL VACCINE PRODUCTION AND MANUFACTURE
#9A CLOSED-SYSTEM UPSTREAM MANUFACTURING PROCESS FOR DENGUE VIRUS PRODUCTION
#10Development of dengue virus vaccine components
#11Modulation of replicative fitness by deoptimization of synonymous codons
#12Compositions and methods for dengue virus chimeric constructions in vaccines
#13MODIFIED GENOMES AND USE THEREOF
#14ATTENUATED DENGUE VIRUSES
#15Development of dengue virus vaccine components
#16Compositions and methods for dengue virus chimeric constructions in vaccines
#17Attenuated virus mutated at sites of evolutionarily conserved RNA structure
#18METHOD FOR EVALUATING ANTI-INFECTIVE DRUGS, VACCINES, ETC. USING IMMORTALIZED MONOCYTIC CELLS AND INDUCED CELLS
#19Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
#20Attenuated flaviviruses
#21Development of dengue virus vaccine components
#22Modulation of replicative fitness by deoptimization of synonymous codons
#23Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein
#24Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
#25Viral synthetic nucleic acid sequences and use thereof
#26Protective anti-ZIKV vaccine without inducing cross-reactions with dengue
#27Genomic sequences encoding for an attenuated mutant Zika virus
#28Development of dengue virus vaccine components
#29Attenuated virus having multiple hosts
#30Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
#31Attenuated virus mutated at sites of evolutionarily conserved RNA structure
#32Modulation of replicative fitness by deoptimization of synonymous codons
#33Development of dengue virus vaccine components
#34Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
#35RNA virus attenuation by alteration of mutational robustness and sequence space
#36MODULATION OF REPLICATIVE FITNESS BY DEOPTIMIZATION OF SYNONYMOUS CODONS
#37Compositions and methods for dengue virus chimeric constructs in vaccines
#38Chimeric West Nile/Dengue viruses and methods of use
#39Attenuated mutant dengue viruses comprising a mutation in the NS4B non-structural protein
#40Flavivirus vaccines
#41Compositions and methods for dengue virus chimeric constructs in vaccines
#42Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
#43Flavivirus envelope protein mutations affecting virion disassembly
#44Flavivirus vaccines
#45Development of dengue virus vaccine components
#46Pseudoinfectious flavivirus and uses thereof
#47Recombinant vaccines
#48Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial Virus
#49Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region
#50Subgenomic replicons of the flavivirus dengue
#51Flavivirus host-range mutations and uses thereof
#52Flavivirus host range mutations and uses thereof
#53Chimeric west nile/dengue viruses
#54Replication-defective flavivirus vaccines and vaccine vectors
#55Chimeric flavivirus vaccines
#56Subgenomic replicons of the flavivirus dengue
#57Development of dengue virus vaccine components
#58Recombinant attenuated dengue viruses comprising a deletion in the 3′ untranslated region and additional attenuating mutations induced by chemical mutagenesis
#59Flavivirus Vaccines
#60Pseudoinfectious and uses thereof
#61West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines
#62Chimeric flaviviruses
#63Recombinant flavivirus vaccines
#64Modulation of replicative fitness by deoptimization of synonymous codons
#65Attenuated flavivirus strains containing a mutated M-ectodomain and their applications
#66Attenuated dengue virus comprising mutations in the NS3 gene
#67Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus
#68Screening for West Nile Virus antiviral therapy
#69Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
#70Flavivirus vaccines